Abstract
Researchers investigated whether pioglitazone was associated with an increased risk of bladder cancer in people with type 2 diabetes.1 Use of pioglitazone, an oral antidiabetic agent in the thiazolidinedione class,...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have